Rite Aid (RAD) Tops Q3 EPS by 1c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
JPMorgan Reiterates Neutral on Rite Aid (RAD) Following 3Q Report
December 21, 2018 7:25 AM ESTJPMorgan analyst, Lisa Gill, reiterated a Neutral rating on Rite-Aid (NYSE: RAD) following the company's 3Q earnings report. Adjusted EBITDA was $13M above forecasts, with upside driven mainly on the gross profit line. Adjusted EPS of +$0.01 compared to estimates of -$0.01.
In the retail... More
Rite Aid (RAD), McKesson (MCK) Announces Terms for Pharmaceutical Purchasing and Distribution
December 19, 2018 4:16 PM ESTRite Aid Corporation (NYSE: RAD) and McKesson Corporation (NYSE: MCK) announced an agreement to key terms that will continue the companies pharmaceutical sourcing and distribution partnership for an additional 10 years. Under these terms, McKesson will continue providing Rite Aid with sourcing and direct-to-store delivery for brand and generic pharmaceutical products through March 2029.
Rite Aid and McKesson have a long history as trusted partners in ensuring the availability of essential medications to patients. The new terms create efficiencies and opportunities for future growth by leveraging the... More
